Greece · Delayed Price · Currency is EUR Medicon Hellas Statistics
Total Valuation
Medicon Hellas has a market cap or net worth of EUR 12.82 million. The enterprise value is 11.68 million.
| Market Cap | 12.82M |
| Enterprise Value | 11.68M |
Important Dates
The next confirmed earnings date is Wednesday, September 30, 2026.
| Earnings Date | Sep 30, 2026 |
| Ex-Dividend Date | Jul 4, 2025 |
Share Statistics
Medicon Hellas has 4.42 million shares outstanding.
| Current Share Class | 4.42M |
| Shares Outstanding | 4.42M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 7.40.
| PE Ratio | 7.40 |
| Forward PE | n/a |
| PS Ratio | 0.71 |
| PB Ratio | 0.65 |
| P/TBV Ratio | 0.66 |
| P/FCF Ratio | 4.40 |
| P/OCF Ratio | 2.91 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 3.15, with an EV/FCF ratio of 4.01.
| EV / Earnings | 6.74 |
| EV / Sales | 0.65 |
| EV / EBITDA | 3.15 |
| EV / EBIT | 5.29 |
| EV / FCF | 4.01 |
Financial Position
The company has a current ratio of 5.18, with a Debt / Equity ratio of 0.47.
| Current Ratio | 5.18 |
| Quick Ratio | 4.31 |
| Debt / Equity | 0.47 |
| Debt / EBITDA | 2.49 |
| Debt / FCF | 3.18 |
| Interest Coverage | 5.52 |
Financial Efficiency
Return on equity (ROE) is 9.23% and return on invested capital (ROIC) is 10.29%.
| Return on Equity (ROE) | 9.23% |
| Return on Assets (ROA) | 4.30% |
| Return on Invested Capital (ROIC) | 10.29% |
| Return on Capital Employed (ROCE) | 7.80% |
| Weighted Average Cost of Capital (WACC) | 5.50% |
| Revenue Per Employee | 121,313 |
| Profits Per Employee | 11,706 |
| Employee Count | 148 |
| Asset Turnover | 0.56 |
| Inventory Turnover | 1.52 |
Taxes
In the past 12 months, Medicon Hellas has paid 302,776 in taxes.
| Income Tax | 302,776 |
| Effective Tax Rate | 14.62% |
Stock Price Statistics
The stock price has increased by +24.46% in the last 52 weeks. The beta is 0.46, so Medicon Hellas's price volatility has been lower than the market average.
| Beta (5Y) | 0.46 |
| 52-Week Price Change | +24.46% |
| 50-Day Moving Average | 2.54 |
| 200-Day Moving Average | 2.55 |
| Relative Strength Index (RSI) | 71.75 |
| Average Volume (20 Days) | 2,481 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Medicon Hellas had revenue of EUR 17.95 million and earned 1.73 million in profits. Earnings per share was 0.39.
| Revenue | 17.95M |
| Gross Profit | 13.11M |
| Operating Income | 2.21M |
| Pretax Income | 2.07M |
| Net Income | 1.73M |
| EBITDA | 3.39M |
| EBIT | 2.21M |
| Earnings Per Share (EPS) | 0.39 |
Balance Sheet
The company has 10.68 million in cash and 9.24 million in debt, with a net cash position of 1.44 million or 0.32 per share.
| Cash & Cash Equivalents | 10.68M |
| Total Debt | 9.24M |
| Net Cash | 1.44M |
| Net Cash Per Share | 0.32 |
| Equity (Book Value) | 19.76M |
| Book Value Per Share | 4.41 |
| Working Capital | 18.31M |
Cash Flow
In the last 12 months, operating cash flow was 4.41 million and capital expenditures -1.50 million, giving a free cash flow of 2.91 million.
| Operating Cash Flow | 4.41M |
| Capital Expenditures | -1.50M |
| Depreciation & Amortization | 1.19M |
| Net Borrowing | -350,743 |
| Free Cash Flow | 2.91M |
| FCF Per Share | 0.66 |
Margins
Gross margin is 73.04%, with operating and profit margins of 12.30% and 9.65%.
| Gross Margin | 73.04% |
| Operating Margin | 12.30% |
| Pretax Margin | 11.54% |
| Profit Margin | 9.65% |
| EBITDA Margin | 18.91% |
| EBIT Margin | 12.30% |
| FCF Margin | 16.21% |
Dividends & Yields
This stock pays an annual dividend of 0.13, which amounts to a dividend yield of 4.48%.
| Dividend Per Share | 0.13 |
| Dividend Yield | 4.48% |
| Dividend Growth (YoY) | 116.67% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 33.16% |
| Buyback Yield | n/a |
| Shareholder Yield | 4.48% |
| Earnings Yield | 13.52% |
| FCF Yield | 22.70% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on July 28, 2004. It was a forward split with a ratio of 1.1.
| Last Split Date | Jul 28, 2004 |
| Split Type | Forward |
| Split Ratio | 1.1 |
Scores
Medicon Hellas has an Altman Z-Score of 2.46 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.46 |
| Piotroski F-Score | 6 |